ORSINI, DIEGO
 Distribuzione geografica
Continente #
AS - Asia 626
NA - Nord America 434
SA - Sud America 123
EU - Europa 121
AF - Africa 30
Totale 1.334
Nazione #
US - Stati Uniti d'America 390
CN - Cina 151
SG - Singapore 149
BD - Bangladesh 139
IT - Italia 93
BR - Brasile 67
HK - Hong Kong 66
VN - Vietnam 33
IN - India 26
AR - Argentina 22
MX - Messico 22
CA - Canada 12
CO - Colombia 9
EC - Ecuador 9
PK - Pakistan 9
ID - Indonesia 8
TN - Tunisia 7
CL - Cile 6
UZ - Uzbekistan 6
VE - Venezuela 6
IQ - Iraq 5
MA - Marocco 5
TR - Turchia 5
EG - Egitto 4
FR - Francia 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
GB - Regno Unito 3
HN - Honduras 3
MY - Malesia 3
UA - Ucraina 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DE - Germania 2
DZ - Algeria 2
ES - Italia 2
ET - Etiopia 2
FI - Finlandia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
PL - Polonia 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
JP - Giappone 1
KH - Cambogia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TG - Togo 1
UY - Uruguay 1
Totale 1.334
Città #
San Jose 229
Singapore 76
Hong Kong 65
Beijing 63
Ashburn 58
Mexico City 19
Ho Chi Minh City 12
Santa Clara 11
New York 10
Milan 9
Figino 7
Rome 7
São Paulo 7
Buffalo 6
Dallas 6
Hanoi 6
Padua 6
Palermo 5
Bari 4
Delhi 4
Los Angeles 4
Medellín 4
Quito 4
Santiago 4
Toronto 4
Baghdad 3
Brooklyn 3
Cairo 3
Casablanca 3
Naples 3
Sousse 3
Tashkent 3
Turin 3
Addis Ababa 2
Bandung 2
Barranquilla 2
Belo Horizonte 2
Buenos Aires 2
Cagliari 2
Caracas 2
Catania 2
Chicago 2
Cleveland 2
Ezeiza 2
Frankfurt am Main 2
Guayaquil 2
Haiphong 2
Hưng Yên 2
Hải Dương 2
Jakarta 2
Jeddah 2
Kuala Lumpur 2
Lahore 2
London 2
Long Beach 2
Montreal 2
Nantes 2
New Delhi 2
Newark 2
Sacramento 2
Seattle 2
Tegucigalpa 2
Thái Bình 2
Tres Arroyos 2
Aci Castello 1
Adrogué 1
Ahmedabad 1
Alexandria 1
Andirá 1
Aracaju 1
Arcugnano 1
Areia Branca 1
Aryanah 1
Austin 1
Avellaneda 1
Badolato 1
Bahía Blanca 1
Baku 1
Bang Lamung 1
Bangkok 1
Barbacena 1
Bathinda 1
Bekasi 1
Belgorod 1
Ben Arous 1
Bengkulu 1
Bethesda 1
Betim 1
Bhīkhi 1
Bishkek 1
Bitonto 1
Biên Hòa 1
Bragado 1
Brasiléia 1
Bristol 1
Buchanan 1
Bắc Ninh 1
Calgary 1
Cali 1
Camaragibe 1
Totale 752
Nome #
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis) 69
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 53
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis) 48
Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort 46
A case of lichen amyloidosus treated with acitretin 46
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis) 46
Neisseria gonorrhoeae Infections 34
Nickel dermatitis from earrings 15 years after EU directive implementation: a clinical-epidemiological study and a market survey in Rome, Italy 32
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis) 28
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 26
Occurrence of salivary gland tumours in two patients treated with biological agents 24
CD4(+)/CD56(+) hematodermic neoplasm 23
Suicide risk and psychiatric comorbidity in patients with psoriasis 23
RNA-based COVID-19 vaccine is not a contraindication to phototherapy: Real-life data on minimal erythema dose changes 23
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 22
Use of biological drugs in patients with psoriasis and psoriatic arthritis in italy: Results from the PSONG survey 22
Classical Kaposi’s sarcoma concurrent with ledipasvir-sofosbuvir therapy for hepatitis C infection 22
EOSINOPHILIC DERMATOSIS ASSOCIATED WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT OF TWO CASES 21
Black lymph node in tattoo: an easy pitfall 21
Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report 21
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders 21
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis) 21
Phototherapy and mycosis fungoides: what's new? 20
Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals 20
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers 20
Stroke Pathway impact on healthcare processes and outcomes: a retrospective observational study 19
Acitretin in management of diffuse common warts: a case report 19
The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus. clinical analysis and results 19
Scleredema adultorum: quali-quantitative analysis of collagen fibers 18
Allergic contact dermatitis to dorzolamide and benzalkonium chloride 18
Dermatitis artefacta: psychological and neurological distress? 18
SARS-CoV-2: an environmental trigger of Darier's disease? 18
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis) 18
Angiomatoid lesions (leukocytoclastic vasculitis) as paraneoplastic manifestations of multiple myeloma IgA lambda 18
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis) 17
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists 17
Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study) 17
Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series 16
Rapid response on facial psoriasis to bimekizumab: case series 16
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study 16
Male and female genital lichen sclerosus. Clinical and functional classification criteria 16
Fingertip dermatitis: a spy for psoriasis 16
Facial Abrikosoff tumour. The role of the dermatologist during COVID-19 pandemic 16
An extrafacial amelanotic lentigo maligna of the leg. a case report 15
The Risk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 15
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study - IL PSO (Italian Landscape Psoriasis) 15
Risankizumab for the treatment of genital psoriasis: a 1-year, real-world experience 15
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 15
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis) 15
Long-term safety of etanercept in psoriasis: Retrospective study focused on infections 15
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series 15
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers 15
An interesting case of oedema and ulceration in red areas of tattoo 14
Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis 14
Long-Term safety and efficacy of adalimumab in psoriasis. A multicentric study focused on infections (connecting study) 14
Stroke pathway performance assessment: a retrospective observational study 13
A RARE CASE OF SARCOIDOSIS AND MORPHEA 13
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study) 13
Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study 13
Lichen ruber planus following connective tissue massage 13
Recreational drugs and STI diagnoses among patients attending an STI/HIV reference clinic in Rome, Italy 13
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis) 12
Space (for) oddity at the skin surface: Enlarged view on the ceramide bio-signature in sebaceous and non sebaceous areas in atopic dermatitis 12
Donovanosis in migrants. a clinical case series in an Italian dermatological hospital 12
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis) 12
Analysing the COVID-19 epidemic in Italy through the Reed-Frost model: A methodology to delimit epidemic waves over time 12
Long-term management of pediatric psoriasis with ixekizumab: a case report 11
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 8
Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio Region 5
Psoriasis in Difficult-to-Treat Areas: A Multicentre, Real-World Retrospective Study Analyzing the Impact of Non-Invasive Imaging Techniques (Dermoscopy, Reflectance Confocal Microscopy and Optical Coherence Tomography) to Monitor the Effectiveness of Risankizumab in the Treatment of Plaque Psoriasis of the Legs 1
Totale 1.404
Categoria #
all - tutte 5.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.355 0 0 18 176 167 44 47 62 377 175 130 159
2026/202749 49 0 0 0 0 0 0 0 0 0 0 0
Totale 1.404